A Phase II Single-Center, Randomized, Double-Blind Study in Subjects with a History of Opioid Abuse to Evaluate the Dose-Response for Flushing and Safety and Tolerability of Varying Doses of Niacin in Combination with 40 mg of an Opioid vs. 40mg of an Opioid Alone
Latest Information Update: 05 Mar 2008
Price :
$35 *
At a glance
- Drugs Niacin (Primary) ; Oxycodone (Primary) ; Oxycodone/niacin (Primary)
- Indications Pain
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Acura Pharmaceuticals
- 05 Mar 2008 New trial record.